Transaction · 0001610717-26-000389

SULIMAN SHEHNAAZ

SULIMAN SHEHNAAZ, DIR, reported an open-market or private sale at 10x Genomics, Inc. involving 1646.000000 shares for an estimated $105288.69. Reported holdings after the transaction were 29515.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
TXG10x Genomics, Inc.
Filing timeAug 26
Trade dateAug 24, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

TXG price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
TXG since 2026-08-26Filed 9 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001610717-26-000389
Class A Common Stock
Transaction date
Aug 24, 2026
Filed Aug 26, 2026, 08:42 PM · 2d delay
Shares
1.64k sh
$6.39k per share
Estimated value
-$10.5M
Computed from shares × price
Holdings after
29.5k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026.

  2. F2

    This transaction was executed in multiple trades at prices ranging from $62.26 to $63.23, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes…

  3. F3

    This transaction was executed in multiple trades at prices ranging from $63.42 to $64.29, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes…

Original filing · 0001610717-26-000389
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

TXG